The single-use assemblies market supports biopharmaceutical and pharmaceutical production with pre-sterilized, disposable components such as bags, filters, tubes, and connectors. Polaris Market Research reports that the market was valued at USD 14.88 billion in 2025 and is projected to reach USD 58.83 billion by 2034, growing at a CAGR of 16.5% from 2026 to 2034, with a 2026 market estimate of USD 16.32 billion. For operations and sourcing teams, performance depends not only on product design but also on supply reliability, outsourcing relationships, and process compatibility. This article focuses on those practical considerations.

Tubing Assemblies and Other Supporting Formats

Bag assemblies and filtration assemblies receive most of the attention in the product segmentation, which also includes bottle assemblies, tubing assemblies, and other formats. According to the report, bottle assemblies and tubing assemblies contribute to market growth through applications in storage, transfer, and process fluid management, although their growth is more niche compared with the two dominant segments. Even so, tubing assemblies remain essential connectors between unit operations, and buyers evaluating a complete single-use train should treat them as a core design decision rather than an afterthought.

Fluid Transfer Assemblies in Practice

Thermo Fisher Scientific Inc. offers a range of single-use assemblies for bioprocessing applications, including fluid transfer assemblies, 2D and 3D BioProcess Containers, and bioprocess drum liners and accessories. According to the report, these solutions minimize the risk of cross-contamination, reduce cleaning requirements, and accelerate implementation timelines. Fluid transfer assemblies illustrate how single-use design shortens setup and removes the need for cleaning and validation that traditional multi-use equipment demands.

Sartorius Stedim Biotech S.A. offers the Sartocon Self-contained Filter Loop Assembly and the Sartocon Slice Self-contained Bag Loop Assembly, both integrating polyethersulfone membranes. These sterile, gamma-sterilized assemblies are pre-wetted and flushed, reducing setup time, and their fully enclosed design supports safe purification of biologics such as vaccines and recombinant proteins in cGMP environments.

Medical-Grade Polymer Supply and Raw Material Risk

The reliability of single-use systems depends heavily on the international supply chain for specialized polymer-based raw materials. As demand for biological products, vaccines, and advanced therapeutics rises, manufacturers face added pressure to source high-quality inputs. The report notes that disruptions in the global supply chain, logistics problems, geopolitical factors, and medical-grade polymer shortages can affect production timelines for single-use products.

To mitigate these risks, material providers will need to increase manufacturing capability, develop infrastructure to supply raw materials on a regional basis, and strengthen sourcing activities. For buyers, consistent access to medical-grade polymer supply is a practical qualification criterion when selecting assembly vendors.

CROs and CMOs: The Fastest-Growing End-User Group

By end user, biopharmaceutical and pharmaceutical companies hold the largest share, at 58.6% in 2025. However, CROs and CMOs are experiencing the fastest growth, supported by the growing trend of outsourcing in the pharmaceutical industry. These organizations need flexible and scalable manufacturing solutions to accommodate various projects and clients, and they benefit from reduced setup and cleaning times that allow faster project turnaround and cost savings. Growing demand for biopharmaceutical outsourcing services further accelerates adoption of single-use assemblies among CROs and CMOs.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/single-use-assemblies-market 

Sterile Bioprocessing Trends

Polaris Market Research highlights several trends shaping sterile bioprocessing. These include a sustainability focus on environmentally friendly, recyclable, and biodegradable single-use products; integration of digital technologies such as real-time monitoring, automation, and data analytics; growing demand for customization and flexibility; and a shift toward modular and scalable manufacturing systems. Advancements in digital technologies are also becoming integrated into single-use systems, providing competitive advantages for companies that invest in them.

Regional Perspective

North America held the largest share, at 37.4% in 2025, supported by major biopharmaceutical companies, robust healthcare infrastructure, and strong regulatory support for biopharmaceutical manufacturing. Asia Pacific is projected to grow at a CAGR of 17.4%, driven by expanding manufacturing capabilities in China and India, where lower manufacturing costs and large-scale production capabilities are attracting local and global pharmaceutical companies. In Europe, countries such as Germany, the UK, and Switzerland are key players in the pharmaceutical sector, and European Medicines Agency guidelines drive demand for reliable and sterile manufacturing processes.

Competitive Strategy and Key Players

Key players identified in the report include Thermo Fisher Scientific Inc.; Sartorius Stedim Biotech S.A.; GE Healthcare Life Sciences; Merck KGaA, Darmstadt, Germany; Danaher Corporation; Pall Corporation; Eppendorf AG; Saint-Gobain Performance Plastics; Bio-Rad Laboratories, Inc.; Lonza Group; Repligen Corporation; Waters Corporation; 3M Company; Becton, Dickinson and Company; and Koch Membrane Systems, Inc. Partnerships and collaborations are described as key strategies for market penetration, with some players working alongside contract manufacturers to expand their offerings. New entrants are advised to focus on innovative product design, environmentally sustainable materials, digital integration, and customizable solutions for niche applications.

Conclusion

As the single-use assemblies market advances toward USD 58.83 billion by 2034, success will depend on more than component quality. Dependable medical-grade polymer supply, well-designed tubing assemblies and fluid transfer assemblies, close alignment with CROs and CMOs, and continued innovation in sterile bioprocessing will shape which suppliers earn long-term trust from biopharmaceutical manufacturers.

More Trending Latest Reports By Polaris Market Research:

Building Information Modeling Market

Innovation Management Market

Coffee Roaster Market

Automotive Dashcam Market

Edge AI Accelerator Market

Industrial Boiler Market

Antifreeze Proteins Market

Unmanned Electronic Warfare Market

Printed Circuit Board Market